“4 get cancer from donated organ,” blared the headline above a news story last week.
A King County program called “Test & Cure” has dramatically increased the numbers of baby boomers screened and treated for
UW Medicine’s heart-transplant team this month began giving all of its patients access to suitable donor hearts from decedents who tested positiv
Surgeons at UW Medicine in Seattle have performed the first liver transplant in the Pacific Northwest involving a warm blood-perfusion device to transport the organ between donor and recipient.
Consistent funding of Veterans Affairs healthcare operations could lead to the cure, within three years, of more than 90 percent of military members currently being treated for hepatitis C, new research suggests.
The virus that causes hepatitis C protects itself by blocking signals that drive elements of liver cells’ immune defenses, report University of Washington researchers and colleagues in a new
New antiviral drugs for hepatitis C have brought a cure within reach for many patients, yet they are highly expensive. A single dose of one of the antivirals costs around $1,000.
The decision by the drugmaker Gilead Science, Inc. to charge $84,000 for a 12-week course of its new hepatitis C drug Sovaldi (sofosbuvir) has churned up protest.
The hepatitis C virus has a previously unrecognized tactic to outwit antiviral responses and sustain a long-term infection.